(678) 384-7220
info@geovax.com
About Us
Company
Management
Board of Directors
Scientific Advisory Board
Technology
MVA-VLP Technology Overview
Gedeptin® Technology Overview
Publications
Pipeline
Pipeline Summary
Immuno-Oncology
Infectious Diseases
Collaborators
Investors
Corporate Profile
News
Events
SEC Filings
GeoVax Stock Information
Corporate Governance
Analyst Coverage
Investor FAQ's
News & Media
Contact
Contact Us
Careers
GeoVax Investor Information
SEC Filings
Group by
None
Year
Date
Description
SEC Form
Download Word
Download Excel
Download PDF
Search:
Clear filters
Year
All
2018
2019
2020
2021
2022
Description
All
8-K
Additional definitive proxy soliciting materials and Rule 14(a)(12) material
Annual Report
Current Report
General Statement of Acquisition of Beneficial Ownership
Notice of Effectiveness
Other Definitive Proxy Statement
Other Definitive Proxy Statements
Other Preliminary Proxy Statements
Post-Effective amendments for registration status
Preliminary Proxy Soliciting Materials
Prospectus
Prospectus Supplement
Quarterly Report
Registration Statement
Year
Date
Description
SEC Form
Download Word
Download Excel
Download PDF
(10)
No records
2020
07-07
Additional definitive proxy soliciting materials and Rule 14(a)(12) material
DEFA 14
View
2020
08-10
Current Report
8-K
View
2020
08-10
Current Report
8-K
View
2020
08-10
Quarterly Report
10-Q
View
2020
09-25
Current Report
8-K
View
2020
09-29
Current Report
8-K
View
2020
10-26
Current Report
8-K
View
2020
11-05
Current Report
8-K
View
2020
11-05
Quarterly Report
10-Q
View
2020
11-05
Prospectus
424B3
View
About GeoVax
Company
Management
Board of Directors
Scientific Advisory Board
Our Technology
Technology Overview
Publications
Investors
Corporate Profile
News
SEC Filings
GeoVax Stock Information
Corporate Governance
Analyst Coverage
Investor FAQ's
Product Pipeline
Pipeline Summary
Immuno-Oncology
Infectious Diseases
Collaborators
SUBSCRIBE FOR UPDATES FROM GEOVAX
Register to receive email alerts for GeoVax press releases
SUBMIT
Name
Search
About Us
Company
Management
Board of Directors
Scientific Advisory Board
Technology
MVA-VLP Technology Overview
Gedeptin® Technology Overview
Publications
Pipeline
Pipeline Summary
Immuno-Oncology
Infectious Diseases
Collaborators
Investors
Corporate Profile
News
Events
SEC Filings
GeoVax Stock Information
Corporate Governance
Analyst Coverage
Investor FAQ's
News & Media
Contact
Contact Us
Careers